SG
BDMDW

StoneX Group’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

StoneX Group’s Portfolio BDMDW Stock Details BDMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,523
Closed -$940 – 1036
2025
Q1 		$940 Buy
+12,523
New +$1.3K ﹤0.01% 855

Other funds holding BDMDW

CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

StoneX Group's BDMDW Position: Q2 2025 in Review

StoneX Group sold out of Baird Medical Investment Holdings Warrant (BDMDW) in Q2 2025, closing a stake of 12,523 shares — an estimated $940 sold.

StoneX Group first reported a position in BDMDW in Q1 2025 and held it in 1 quarter. The position peaked at $940 in Q1 2025. 32 funds tracked by Wall St. Rank hold BDMDW as of Q2 2025.

  • StoneX Group reported no remaining Baird Medical Investment Holdings Warrant position as of Q2 2025 after selling out during the quarter.
  • StoneX Group sold 12,523 Baird Medical Investment Holdings Warrant shares in Q2 2025, an estimated $940.
  • StoneX Group first reported a position in Baird Medical Investment Holdings Warrant in Q1 2025 and held it in 1 quarter.
  • StoneX Group's Baird Medical Investment Holdings Warrant position peaked at $940 in Q1 2025.
  • 32 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q2 2025.

Based on StoneX Group's 13F filing for Q2 2025, filed 13 Aug 2025.